Delivery Order SPE2DB22D1106-SPE2DB25FDHM3
Award Date
10/17/24
Potential Completion Date
10/18/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,162.20 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 19, 2025, with a period of performance through February 20, 2025. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Buprenorphine 20 mcg/hr patches to the Defense Logistics Agency (DLA). The $1,658.72 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 13, 2023. The contract has an ultimate completion date of April 14, 2023 and was not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a pain management medication, to the Defense Logistics Agency (DLA). The $2,422.28 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 1, 2021, with a completion date of November 2, 2021. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Buprenorphine 20 MCG/HR Patch 4S. The $1,946.84 firm fixed-price contract has a completion date of June 21, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX15D2213|SPE2DX24F7X9X, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,954,459 units of Buprenorphine 20 mcg/hr Patches. The award has a ceiling value of $1,056.00 and an ultimate completion date of December 1, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any...
This federal contract award is for the delivery of Buprenorphine 10 MCG/HR Patch 4S, a medication used for pain management. The contract, valued at $1,968.62, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the Defense Logistics Agency (DLA) Troop Support Medical, valued at up...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,427.27, is for the supply of Buprenorphine 20 mcg/hr Patch to the government. The contract is a firm fixed-price delivery order with a completion date of April 30, 2024. There is no set-aside designation for this contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the delivery of Buprenorphine 20 mcg/hr Patch 4s, a specialty pharmaceutical product. The contract, valued at $1,060.77, has an ultimate completion date of April 21, 2023. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Buprenorphine 20 mcg/hr transdermal patches. The contract has a firm fixed price of $1,351.69 and a period of performance through September 6, 2024. The award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
This is a delivery order issued under a federal Indefinite Delivery Contract (IDC) by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,601.04 firm fixed-price award is for the supply of 4,565,705,592 units of Buprenorphine 15 MCG/HR Patches. The contract has a period of performance through September 9, 2024 and does not have a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in...